A carregar...
Detection of Alzheimer’s Disease Pathology in patients using biochemical biomarkers: prospects and challenges for use in clinical practice.
BACKGROUND: Amyloid-β1-42 peptide was identified 34 years ago in amyloid plaques obtained from Alzheimer’s disease (AD) and Down’s Syndrome patients’ autopsied brain tissue. This led to development of immunoassay methods for measuring this marker of amyloid plaque burden in cerebrospinal fluid (CSF)...
Na minha lista:
| Publicado no: | J Appl Lab Med |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7246169/ https://ncbi.nlm.nih.gov/pubmed/31848218 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1373/jalm.2019.029587 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|